Skip to main content
. Author manuscript; available in PMC: 2022 Mar 4.
Published in final edited form as: Circ Cardiovasc Interv. 2021 Jul 13;14(7):e009328. doi: 10.1161/CIRCINTERVENTIONS.120.009328

Table.

Prevalence of TRI, Incidence of Adverse Outcomes, and Risk Categories

Characteristic Before 2015 2015 and after
N=16 978 N=11 027
TRI 697 (4.11) 2562 (23.23)
Preprocedural risks
 Bleeding
  Low risk 4101 (24.15) 2273 (20.61)
  Moderate risk 9376 (49.33) 5231 (47.44)
  High risk 4501 (26.51) 3523 (31.95)
 Acute kidney injury*
  Low risk 6763 (44.86) 3157 (33.24)
  Moderate risk 3305 (21.92) 2109 (22.20)
  High risk 5009 (33.22) 4232 (44.56)
 Death
  Low risk 11 380 (67.03) 6657 (60.43)
  Moderate risk 5322 (31.35) 4065 (36.90)
  High risk 275 (1.62) 294 (2.67)
Proportion with event
 Bleeding 624 (3.68) 336 (3.05)
 Acute kidney injury 787 (5.22) 496 (5.22)
 Death 168 (0.99) 131 (1.19)

TRI indicates transradial percutaneous coronary intervention.

*

Data available on 15 077 patients before 2015 and 9498 patients since 2015 (total 24 575 patients).